Skip to main content
Back
GLPG logo

Galapagos N.V.

Data quality: 100%
GLPG
NASDAQ Healthcare Biotechnology
$31.90
▼ $0.11 (-0.34%)
Mkt Cap: 2.10B
Also listed as GLPGF OTC
Day Range
$31.70 $32.37
52-Week Range
$22.59 $37.78
Volume
94,324
50D / 200D Avg
$33.57 / $32.14
Prev Close
$32.01

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E 6.6 0.4
P/B 0.7 2.9
ROE % 10.5 3.8
Net Margin % 28.9 3.9
Rev Growth 5Y % 23.1 10.0
D/E 0.0 0.2

Key Takeaways

Revenue grew 23.07% annually over 5 years — strong growth
Earnings grew 333.17% over the past year
ROE of 10.47% — decent returns on equity
Net margin of 28.85% shows strong profitability
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -202.40M

Growth

Revenue Growth (5Y)
23.07%
Revenue (1Y)303.48%
Earnings (1Y)333.17%
FCF Growth (3Y)N/A

Quality

Return on Equity
10.47%
ROIC10.42%
Net Margin28.85%
Op. Margin40.56%

Safety

Debt / Equity
0.00
Current Ratio20.15
Interest Coverage164.04

Valuation

P/E Ratio
6.55
P/B Ratio0.65
EV/EBITDA4.49
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 303.48% Revenue Growth (3Y) 115.40%
Earnings Growth (1Y) 333.17% Earnings Growth (3Y) 23.12%
Revenue Growth (5Y) 23.07% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.11B Net Income (TTM) 320.90M
ROE 10.47% ROA 9.42%
Gross Margin 93.49% Operating Margin 40.56%
Net Margin 28.85% Free Cash Flow (TTM) -202.40M
ROIC 10.42% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.00 Current Ratio 20.15
Interest Coverage 164.04 Dividend Yield 0.00%
Valuation
P/E Ratio 6.55 P/B Ratio 0.65
P/S Ratio 1.89 PEG Ratio 0.02
EV/EBITDA 4.49 Dividend Yield 0.00%
Market Cap 2.10B Enterprise Value 2.03B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.11B 275.65M 239.72M 241.25M 484.85M
Net Income 320.90M 74.08M 211.70M -217.99M -125.42M
EPS (Diluted) 4.85 1.12 -0.06 -3.32 -1.91
Gross Profit 1.04B 240.79M 239.72M 241.25M 483.22M
Operating Income 451.12M -188.34M -88.26M -131.06M -165.60M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 3.41B 4.14B 4.36B 4.73B 5.19B
Total Liabilities 170.58M 1.24B 1.56B 2.21B 2.55B
Shareholders' Equity 3.23B 2.90B 2.80B 2.53B 2.64B
Total Debt 12.10M 11.72M 9.60M 21.90M 26.86M
Cash & Equivalents 87.83M 64.24M 166.80M 508.12M 2.23B
Current Assets 3.08B 3.34B 3.86B 4.24B 4.86B
Current Liabilities 152.80M 335.08M 428.22M 522.54M 566.47M

Strategy Scores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Value Defensive Investing (Benjamin Graham)
#163 of 708
46
Custom Full Throttle
#87 of 146
39

Recent Activity

Entered Defensive Investing (Benjamin Graham)
Mar 24, 2026
Entered Full Throttle
Mar 24, 2026